Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA polymerase is an enzyme essential for the synthesis of DNA molecules from deoxynucleoside triphosphates, playing a central role in DNA replication and repair in all living cells[1][5][6]. Inhibitors of DNA polymerase block DNA strand elongation or incorporation, interfering with DNA replication and cell division; this mechanism underlies the action of several anticancer and antiviral drugs[6]. DNA polymerases exist in multiple families (A, B, C, D, X, Y, RT) with specialized functions, structures likened to a right hand with palm, fingers, and thumb subdomains, and typically require divalent metal ions for catalytic activity[2][5][6][8]. Because inhibition of DNA polymerases halts cell proliferation, these enzymes are important therapeutic targets but also pose a risk for toxicity in normal, rapidly dividing cells[6]. Additional details: - "DNA polymerase-mediated DNA synthesis inhibition" is not a canonical target name; the correct target is the enzyme "DNA polymerase". - Multiple small molecule and nucleoside analog drugs inhibit DNA polymerase directly or via incorporation as chain terminators, which is a key therapeutic principle in oncology and antiviral therapy[6]. - Different classes of DNA polymerase exist, including those primarily involved in replication (e.g., polymerase α, δ, ε in eukaryotes) or repair (e.g., polymerase β, λ, μ)[6][8]. - Significant safety concerns arise from inhibition of host DNA polymerases in non-target tissues, particularly in bone marrow, gastrointestinal tract, and in mitochondrial DNA replication (mitochondrial toxicity)[6].
Polymerase inhibition, Chain termination, Competitive inhibition of nucleotide incorporation
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA polymerase.